Search tendencies of information about Emtricitabine/Tenofovir and the pre-exposure prophylaxis of HIV in Spain: ecological study
DOI:
https://doi.org/10.19230/jonnpr.3834Keywords:
Emtricitabine, Tenofovir, Pre-Exposure Prophylaxis, Unsafe Sex, Information Management, Information Literacy, Social Media, Google TrendsAbstract
Objective. Relate the information serch tendencies about Emtricitabine/Tenofovir and Preexposure prophylaxis for the human immunodeficiency virus (HIV) in Spain.
Methods. Ecological study of the relative search volumen obtained from direct consultation to the tool «Google Trends», using the search topics «Emtricitabine/Tenofovir» and «Pre-exposure prophylaxis for HIV», and «Truvada» as search term. The search periodo from January 1, 2004 to December 31, 2019. Inquiry date January 23, 2020.
Results. The VBR = 100, máximum, it was achieved in October 2019 for «Pre-exposure prophylaxis for HIV», being the relationship between the terms of 100/17/15. The association between «Emtricitabine/Tenofovir» and «Truvada» was very high (R = 0,99; p < 0,001). And the mean of the VBR for «Emtricitabine/Tenofovir» and «Pre-exposure prophylaxis for HIV» were 12.20 and 27.20 respectively. The VBR tendencies for «Emtricitabine / Tenofovir» was slightly increasing with linear adjustment (R2 = 0.05; p <0.02), for «Pre-exposure prophylaxis for HIV» it was moderately increasing with exponential adjustment (R2 = 0.20; p <0.001). The correlation between the VBR data of the two topics analyzed didn’t show an association between them (R = 0.04; p = 0.595).
Conclusions. Growth was found over time in the search of information on both the Emtricitabine/Tenofovir and HIV Pre-Exposure Prophylaxis Topics, although the existence of an association between both Topics could not be proved. The increased search for this information could be related to the increased interest in the prevention of risk sexual practices related to HIV.
Downloads
References
World Health Organization (WHO). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendations for a public health approach [monografía en Internet]. Geneva, Switzerland: WHO; 2016 [citado 3 de abril de 2020]. Disponible en: https://bit.ly/3dTr3YZ
Leddy AM, Weiss E, Yam E, Pulerwitz J. Gender-based violence and engagement in biomedical HIV prevention, care and treatment: a scoping review. BMC Public Health. 2019;19(1):897. DOI: 10.1186/s12889-019-7192-4
Buchbinder SP, Liu AY. CROI 2019: advances in HIV prevention and plans to end the epidemic. Top Antivir Med. 2019;27(1):8-25.
To KW, Lee SS. HIV pre-exposure prophylaxis in South East Asia: A focused review on present situation. Int J Infect Dis. 2018;77:113-7. DOI: 10.1016/j.ijid.2018.10.027
Plan Nacional sobre el Sida-Grupo de Expertos PrEP. Documento de Consenso: Profilaxis Preexposición al VIH en España [monografía en Internet]. Madrid, España: Dirección General de Salud Pública, Calidad e Innovación del Ministerio de Sanidad, Servicios Sociales e Igualdad; 2018 [citado 20 de abril de 2020]. Disponible en: https://bit.ly/2VCaidS
Alaei K, Paynter CA, Juan S-C, Alaei A. Using preexposure prophylaxis, losing condoms? Preexposure prophylaxis promotion may undermine safe sex: AIDS. 2016;30(18):2753-6. DOI: 10.1097/QAD.0000000000001262
Scott HM, Klausner JD. Sexually transmitted infections and pre-exposure prophylaxis: challenges and opportunities among men who have sex with men in the US. AIDS Res Ther. 2016;13:5. DOI: 10.1186/s12981-016- 0089-8
World Health Organization (WHO). Global strategy for the prevention and control of sexually transmitted infections: 2006 - 2015 [monografía en Internet]. Geneva, Switzerland: WHO; 2007 [citado 3 de abril de 2020]. Disponible en: https://bit.ly/2R5wkRf
Koechlin FM, Fonner VA, Dalglish SL, O’Reilly KR, Baggaley R, Grant RM, et al. Values and Preferences on the Use of Oral Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Multiple Populations: A Systematic Review of the Literature. AIDS Behav. 2017;21(5):1325-35. DOI: 10.1007/s10461-016-1627-z
Sanchez Conde M, Vivancos Gallego MJ, Moreno Guillen S. Pre-exposure prophylaxis (PrEP) against HIV: efficacy, safety and uncertainties. Farm Hosp. 2017;41(5):630-7. DOI: 10.7399/fh.10821
Giorgetti R, Tagliabracci A, Schifano F, Zaami S, Marinelli E, Busardò FP. When «Chems» Meet Sex: A Rising Phenomenon Called «ChemSex». Curr Neuropharmacol. 2017;15(5):762-70. DOI: 10.2174/1570159X15666161117151148
Stevens O, Forrest JI. Thinking upstream: the roles of international health and drug policies in public health responses to chemsex. Sex Health. 2018;15(2):108-15. DOI: 10.1071/SH17153
Pelat C, Turbelin C, Bar-Hen A, Flahault A, Valleron A-J. More diseases tracked by using Google Trends. Emerging Infect Dis. 2009;15(8):1327-8. DOI: 10.3201/eid1508.090299
Sanz-Lorente M, Wanden-Berghe C. Tendencias temporales de los patrones de búsqueda de información sobre cuidado domiciliario “Home Care” u hospitalario “Hospital Care” a través de Google. Hosp Domic. 2018;2(3):93-9. DOI: 10.22585/hospdomic.v2i3.47
Amazon Company. Alexa, Top Sites (The top 500 sites on the Web) [página Web]. [citado 21 de marzo de 2020]. Disponible en: http://www.alexa.com/topsites
Orduña-Malea E. Google Trends: analítica de búsquedas al servicio del investigador, del profesional y del curioso de la información. ThinKEPI. 2019;13:e13inf01. DOI: 10.3145/thinkepi.2019.e13inf01
Eysenbach G. Infodemiology and infoveillance: framework for an emerging set of public health informatics methods to analyze search, communication and publication behavior on the Internet. J Med Internet Res. 2009;11(1):e11. DOI: 10.2196/jmir.1157
Mavragani A, Ochoa G, Tsagarakis KP. Assessing the methods, tools, and statistical approaches in Google Trends research: systematic review. J Med Internet Res. 2018;20(11):e270. DOI: 10.2196/jmir.9366
Sanz-Lorente M. Tendencias temporales de los patrones de búsqueda de información sobre servicio de asistencia sanitaria domiciliaria en España. Hosp Domic. 2020;4(1):15-23. DOI: 10.22585/hospdomic.v4i1.95
Domingo Calvo M. Comparativa de herramientas de SEO para Keywords Discovery [monografía en Internet]. Valencia, España: Escola Tècnica Superior d’Enginyeria Informàtica Universitat Politècnica de València; 2017 [citado 23 de abril de 2020]. Disponible en: https://bit.ly/2VwGpvu
Sanz-Lorente M, Sanz-Valero J, Wanden-Berghe C. Tendencias temporales de los patrones de búsqueda de información sobre VIH/sida en España. Rev Esp Comun Salud. 2019;(Supl 2):S52-60. DOI: 10.20318/recs.2019.4554
Ortiz-Martinez Y, Rios-González CM. Global impact of the World Hepatitis Day 2016: An evaluation using Google Trends. J Infect Public Health. 2017;10(5):690-1. DOI: 10.1016/j.jiph.2016.09.015
U.S. Food and Drug Administration (FDA). Drug Approval Package: Truvada (Emtricitabine and Tenofovir Disoproxil Fumarate) Tablets [monografía en Internet]. Silver Spring, USA: FDA; 2004 [citado 20 de abril de 2020]. Disponible en: https://bit.ly/2Kv3OqI
Centro de prensa. 22.a Conferencia Internacional sobre el Sida [monografía en Internet]. Amsterdam, Países Bajos: Organización Mundial de la Salud; 2018 [citado 17 de abril de 2020]. Disponible en: https://bit.ly/3aitO3d
Resolución de 28 de junio de 2018, de la Secretaría General de Sanidad y Consumo, por la que se publica la Adenda al Convenio entre la Dirección General de Salud Pública, Calidad e Innovación y Gilead Sciences, SLU, en el contexto del estudio sobre evaluación de la factibilidad de la implementación de la profilaxis preexposición (PrEP), como estrategia de prevención de la infección por el VIH en población de alto riesgo en el Sistema Nacional de Salud. Boletín Oficial del Estado, no 169 (13 de julio de 2018).
Ministerio de Sanidad, Consumo y Bienestar Social. Notas de Prensa: El Sistema Nacional de Salud (SNS) financia la PrEP desde mañana como medida de prevención del VIH en personas de alto riesgo [monografía en Internet]. Madrid, España: Ministerio de Sanidad, Consumo y Bienestar Social; 2019 [citado 25 de abril de 2020]. Disponible en: https://bit.ly/358BAM6
Johnson AK, Mehta SD. A comparison of Internet search trends and sexually transmitted infection rates using Google trends. Sex Transm Dis. 2014;41(1):61-3. DOI: 10.1097/OLQ.0000000000000065
Sheshadri K, Singh MP. The public and legislative impact of hyperconcentrated topic news. Sci Adv. 2019;5(8):eaat8296. DOI: 10.1126/sciadv.aat8296
Serrano Cobos J. Pasado, presente y futuro de la Web 2.0 en servicios de información digital. Rev BID. 2006; (17):e17serra2.
Aguirre PEA, Strieder AP, Lotto M, Oliveira TM, Rios D, Cruvinel AFP, et al. Are the Internet users concerned about molar incisor hypomineralization? An infoveillance study. Int J Paediatr Dent. 2020;30(1):27-34. DOI: 10.1111/ipd.12579
Cervellin G, Comelli I, Lippi G. Is Google Trends a reliable tool for digital epidemiology? Insights from different clinical settings. J Epidemiol Glob Health. 2017;7(3):185-9. DOI: 10.1016/j.jegh.2017.06.001
Published
Issue
Section
License
All accepted originals remain the property of JONNPR. In the event of publication, the authors exclusively transfer their rights of reproduction, distribution, translation and public communication (by any sound, audiovisual or electronic medium or format) of their work. To do so, the authors shall sign a letter transferring these rights when sending the paper via the online manuscript management system.
The articles published in the journal are freely used under the terms of the Creative Commons BY NC SA license, therefore.
You are free to:
Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial — You may not use the material for commercial purposes.
ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
